Update in chronic obstructive pulmonary disease 2005. (Q36470462)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16679444%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

review article

1 reference

title

Update in chronic obstructive pulmonary disease 2005 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16679444%20AND%20SRC:MED&resulttype=core&format=json

chronic obstructive pulmonary disease

20 January 2020

main subject

1 reference

Fabrizio Luppi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16679444%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Bianca Beghé

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16679444%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

English

0 references

publication date

1 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16679444%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Respiratory and Critical Care Medicine

20 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16679444%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

173

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16679444%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16679444%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

1056-1065

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16679444%20AND%20SRC:MED&resulttype=core&format=json

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Preventing chronic diseases: how many lives can we save?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

One hundred years of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

The pathogenesis of chronic obstructive pulmonary disease: advances in the past 100 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Abdominal muscle and quadriceps strength in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Systemic inflammation in COPD visualised by gene profiling in peripheral blood neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

The role of smoking in coagulation and thromboembolism in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Local and systemic inflammation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Increased arterial carboxyhemoglobin concentrations in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Chronic obstructive pulmonary disease: current burden and future projections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Patterns of comorbidities in newly diagnosed COPD and asthma in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Survival of chronic hypercapnic COPD patients is predicted by smoking habits, comorbidity, and hypoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Mortality in individuals with severe deficiency of alpha1-antitrypsin: findings from the National Heart, Lung, and Blood Institute Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Burden and clinical features of chronic obstructive pulmonary disease (COPD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Prevalence of physician-diagnosed COPD and its association with smoking among urban and rural residents in regional mainland China

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Prevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD and ATS criteria in relation to doctor's diagnosis, symptoms, age, gender, and smoking habits

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Polymorphisms of the ADAM33 gene are associated with accelerated lung function decline in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

A disintegrin and metalloprotease 33 polymorphisms and lung function decline in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Matrix metalloproteinase-9 promoter polymorphism associated with upper lung dominant emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Pathophysiology of airflow limitation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Elastolytic proteases: inflammation resolution and dysregulation in chronic infective lung disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

A functional mutation in the terminal exon of elastin in severe, early-onset chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Secretory phospholipases A2 in inflammatory and allergic diseases: not just enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

A novel polymorphism in secretory phospholipase A2-IID is associated with body weight loss in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

The nature of small-airway obstruction in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Tumor necrosis factor-alpha overexpression in lung disease: a single cause behind a complex phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

A distinctive alveolar macrophage activation state induced by cigarette smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Decreased expression of TGF-beta type II receptor in bronchial glands of smokers with COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Obstructive airway diseases in women exposed to biomass smoke

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Correlation between suspended particles in the environmental air and causes of disease among inhabitants: cross-sectional studies using the vital statistics and air pollution data in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Associations between health effects and particulate matter and black carbon in subjects with respiratory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Long-term air pollution exposure and living close to busy roads are associated with COPD in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Lung function decline, chronic bronchitis, and occupational exposures in young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Ten-year cumulative incidence of COPD and risk factors for incident disease in a symptomatic cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Nitrosative stress in the bronchial mucosa of severe chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Peroxynitrite and drug-dependent toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

The association of acetaminophen, aspirin, and ibuprofen with respiratory disease and lung function

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Lipid peroxidation and 5-lipoxygenase activity in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Oxidative stress and airway inflammation in severe exacerbations of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Nitrosative stress, heme oxygenase-1 expression and airway inflammation during severe exacerbations of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Hypoxaemia enhances peripheral muscle oxidative stress in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Pulmonary rehabilitation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Rehabilitation decreases exercise-induced oxidative stress in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Effects of corticosteroids on noninvasive biomarkers of inflammation in asthma and chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Steroid-resistant inflammation in a rat model of chronic obstructive pulmonary disease is associated with a lack of nuclear factor-kappaB pathway activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Decreased histone deacetylase activity in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Histone acetylation and deacetylation: importance in inflammatory lung diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

COPD: current therapeutic interventions and future approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Bronchial CD8 cell infiltrate and lung function decline in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Marked alveolar apoptosis/proliferation imbalance in end-stage emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Adrenomedullin regenerates alveoli and vasculature in elastase-induced pulmonary emphysema in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Induction of compensatory lung growth in pulmonary emphysema improves surgical outcomes in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Clinical implications for statin pleiotropy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Effects of simvastatin on cigarette smoking-induced structural and functional changes in rat lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Outcomes and markers in the assessment of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

A multidimensional grading system (BODE index) as predictor of hospitalization for COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Recommendations for the management of cough in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Characteristics of physical activities in daily life in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Walking versus cycling: sensitivity to bronchodilation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Severe pulmonary hypertension and chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Pulmonary hypertension and chronic obstructive pulmonary disease: a case for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Pulmonary hypertension in chronic obstructive pulmonary disease: current theories of pathogenesis and their implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

The prediction of small airway dimensions using computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Assessment of emphysema in COPD: a functional and radiologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Dissociation of lung function and airway inflammation in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Diaphragm dysfunction in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

How should COPD patients exercise during respiratory rehabilitation? Comparison of exercise modalities and intensities to treat skeletal muscle dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Skeletal muscle adaptations to interval training in patients with advanced COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Adenine nucleotide loss in the skeletal muscles during exercise in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Contractile fatigue, muscle morphometry, and blood lactate in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

HYPOGONADISM AND METABOLIC SYNDROME: IMPLICATIONS FOR TESTOSTERONE THERAPY

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Hypogonadism, quadriceps weakness, and exercise intolerance in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Hypogonadism in men with chronic obstructive pulmonary disease: prevalence and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Respiratory and skeletal muscles in hypogonadal men with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Hypogonadism in elderly men--what to do until the evidence comes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Factors affecting survival of hospitalised patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Physiological changes during symptom recovery from moderate exacerbations of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Lung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Exacerbations and time spent outdoors in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Relevance of human metapneumovirus in exacerbations of COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Pathogenesis and treatment of acute exacerbations of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Guidelines for the management of adult lower respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Does bacterial colonization play a role in acute respiratory failure in chronic obstructive pulmonary disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Microbial airway colonization is associated with noninvasive ventilation failure in exacerbation of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Haemophilus influenzae from patients with chronic obstructive pulmonary disease exacerbation induce more inflammation than colonizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Respiratory viral infections in patients with chronic, obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Overview of virus-induced airway disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Childhood respiratory infections and hospital admissions for COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

The role of corticosteroids in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Nutritional management of the patient with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Treatment of cachexia with ghrelin in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

The TORCH (towards a revolution in COPD health) survival study protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Roflumilast--an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Cilomilast for COPD: results of a 6-month, placebo-controlled study of a potent, selective inhibitor of phosphodiesterase 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Roflumilast fully prevents emphysema in mice chronically exposed to cigarette smoke

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

TNF-alpha-, TNF-beta-, IL-6-, and IL-10-promoter polymorphisms in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

First study of infliximab treatment in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Retinoic acid induces alveolar regeneration in the adult mouse lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

On the role of surface tension in the pathophysiology of emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Prescription of oxygen: still problems after all these years

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

A randomized trial of strategies for assessing eligibility for long-term domiciliary oxygen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Effect of bronchoscopic lung volume reduction on dynamic hyperinflation and exercise in emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Small airway morphometry and improvement in pulmonary function after lung volume reduction surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Diaphragm length and neural drive after lung volume reduction surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Preventing chronic diseases: taking stepwise action

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Cryptic haplotypes ofSERPINA1confer susceptibility to chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Pathogenesis of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

Systemic Effects of Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2603005

21 January 2018

Identifiers

DOI

10.1164/RCCM.2603005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16679444%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16679444%20AND%20SRC:MED&resulttype=core&format=json